Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

513.26
-1.3700-0.27%
Post-market: 513.400.1400+0.03%19:52 EDT
Volume:638.48K
Turnover:328.18M
Market Cap:130.22B
PE:29.87
High:517.95
Open:513.80
Low:511.35
Close:514.63
52wk High:560.25
52wk Low:374.17
Shares:253.72M
Float Shares:253.72M
Volume Ratio:0.74
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.43
PE(LYR):33.50

Loading ...

Vertex options imply 5.4% move in share price post-earnings

TIPRANKS
·
Aug 04

3 US Stocks Built For Tariff Driven Supply Chain Shifts

Simply Wall St.
·
Aug 03

Tyson Foods, Marriott And 3 Stocks To Watch Heading Into Monday

Benzinga Earnings
·
Aug 03

Vertex Minerals Director Increases Stake via Share Purchase Plan

TIPRANKS
·
Aug 03

Vertex Minerals Director Lifts Stake and Supports Financing via Convertible Loan

TIPRANKS
·
Aug 03

Vertex Minerals Seeks Quotation for 8.58 Million New Shares

TIPRANKS
·
Aug 03

Vertex Minerals bolsters balance sheet with successful share purchase plan

TIPRANKS
·
Aug 03

Vertex Minerals prioritises Reward mine development as funding and recoveries strengthen

TIPRANKS
·
Jul 31

New Vertex Research Signals a Turning Point for Indirect Tax and Compliance: The Rise of Decision-to-Defense

GlobeNewswire
·
Jul 30

AbCellera and Vertex launch autoimmune T-cell engager partnership

TIPRANKS
·
Jul 30

Abcellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions

THOMSON REUTERS
·
Jul 29

Abcellera Biologics - Vertex to Fund All R&D and Commercialize Antibodies from Collaboration

THOMSON REUTERS
·
Jul 29

Abcellera Biologics - Abccellera to Receive $28 Mln Upfront Plus Milestone Payments and Tiered Royalties

THOMSON REUTERS
·
Jul 29

Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 29

Analysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN), Zoetis (ZTS) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jul 28

Crinetics downgraded to Neutral from Buy at UBS

TIPRANKS
·
Jul 28

Earning Preview: Vertex Pharmaceuticals this quarter’s revenue is expected to increase by 11.23%, and institutional views are bullish

Earnings Agent
·
Jul 27

Vertex Minerals appoints independent expert after multiple ASX Listing Rule breaches

TIPRANKS
·
Jul 23

Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 23

What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunity

TIPRANKS
·
Jul 22